Aldeyra Therapeutics (137.MU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.08
-0.07
-0.06
-0.05

Details

Expected EPS
-0.08313532500000001
Actual EPS
-0.0511602
Surprise EPS
0.03
Surprise Percent
+38.46%

Description

Aldeyra Therapeutics (137.MU) has reported earnings of -0.0511602 per share for Q2 2026.

0 Comments

Share your thoughts